(BPT) - Davitria lives with two mental illnesses and tardive dyskinesia.This article was sponsored and developed by Neurocrine Biosciences, Inc. Davitria was compensated by Neurocrine Biosciences to …
/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application.
NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders,
/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual.